Breathe Anew for Lung Cancer Survivorship
BA
Breathe Anew: Designing and Testing the Feasibility of a Novel Intervention for Lung Cancer Survivorship
1 other identifier
interventional
50
1 country
1
Brief Summary
Survivorship programs have become an integral component of modern cancer care programs. In Canada, there has been tremendous success for survivorship programs for breast, prostate, and colorectal cancer, however lung cancer survivorship programs have not been widely developed. The complexity of the disease, high mortality, short survival times, high cost of surveillance, and patient habits have traditionally been barriers against the success of lung cancer survivorship programs. The investigator proposes a feasibility study to pilot a novel intervention titled Breathe Anew, which will aim to identify and overcome the barriers to the design and implementation of a lung cancer survivorship program. The investigator has assembled a multi-disciplinary team of experts and lung cancer survivors who will develop the Breathe Anew survivorship intervention. The intervention will be vetted using an integrated knowledge translation approach, which will involve members of the target population, primarily patients who previously underwent lung resection, to modify the intervention and ensure acceptability. After Breathe Anew has been designed, it will be tested in a pilot study of 50 patients to ensure its feasibility and determine its cost. The ultimate goal of this feasibility study is to lay the groundwork for a subsequent comparative trial to evaluate the impact of Breathe Anew on patient-important outcomes including health related quality and length of life and postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 lung-cancer
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2018
CompletedFirst Posted
Study publicly available on registry
December 12, 2018
CompletedStudy Start
First participant enrolled
January 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedMarch 4, 2022
March 1, 2022
3 years
December 10, 2018
March 3, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Compliance
The feasibility of Breath Anew, as measured by a rate of compliance of \>70% with all the components of the intervention.
12 months
Secondary Outcomes (3)
Accrual Rate
12 months
Patient-Reported Satisfaction
12 months
Cost Per Patient
12 months
Study Arms (1)
Feasibility
EXPERIMENTAL50 patients will be recruited to take part in this feasibility study. They will all undergo this Breathe Anew Program post-surgery. Breathe Anew consists of radiological surveillance, physical rehabilitation using a Fitbit, mindfulness therapy, and referral for symptom management specialists when needed.
Interventions
The feasibility will be tested of the Breathe Anew Survivorship Program
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- All patients at St. Joseph's Healthcare Hamilton who received lung resection for Stage I, Stage II, or Stage IIIa Non-Small Cell Lung Cancer are eligible to enroll.
- Owns a smart device
You may not qualify if:
- Patients who received lung resection for Stage IIIb or IV Non-Small Cell Lung Cancer
- Patients with affected mobility (walker, wheelchair)
- Patients who use oxygen at home
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Surgery
Study Record Dates
First Submitted
December 10, 2018
First Posted
December 12, 2018
Study Start
January 2, 2019
Primary Completion
January 1, 2022
Study Completion
January 1, 2022
Last Updated
March 4, 2022
Record last verified: 2022-03